Compare BNR & NUCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | NUCL |
|---|---|---|
| Founded | 2014 | 2023 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.5M | 141.4M |
| IPO Year | 2019 | 2026 |
| Metric | BNR | NUCL |
|---|---|---|
| Price | $13.00 | $4.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.4K | ★ 194.0K |
| Earning Date | 11-23-2026 | 10-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $101.46 | N/A |
| Revenue Next Year | $14.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.79 | $3.51 |
| 52 Week High | $41.72 | $14.22 |
| Indicator | BNR | NUCL |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 29.00 |
| Support Level | $9.12 | N/A |
| Resistance Level | $19.10 | $6.45 |
| Average True Range (ATR) | 1.26 | 0.36 |
| MACD | 0.16 | -0.02 |
| Stochastic Oscillator | 88.67 | 38.19 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds rights to the mineable, measured, and indicated uranium deposit in the United States, known as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated resource of 32.75 million pounds (Indicated) and 4.98 million pounds (Inferred) of near-surface uranium, and the adjacent Cordex zone.